Medicine and Dentistry
Positron Emission Tomography - Magnetic Resonance Imaging
72%
Positron Emission Tomography
70%
Positron Emission Tomography
38%
Positron Emission Tomography-Computed Tomography
38%
Magnetic Resonance Imaging
35%
Lung Cancer
28%
Magnetic Resonance Imaging
26%
Fluorine-18
24%
Oncology
20%
Fluorodeoxyglucose F 18
19%
Reproducibility
17%
Neoplasm
16%
Atherosclerosis
14%
Treatment Response
13%
Whole Body PET
13%
Radiation Therapy Planning
11%
Prospective Study
11%
Pelvis
10%
Clinical Study
10%
Malignant Neoplasm
9%
Diffusion MRI
9%
Fluorodeoxyglucose
9%
Neoadjuvant Therapy
8%
Metastatic Colon Cancer
8%
Glucagon-Like Peptide-1 Agonist
8%
Gene Expression
8%
Liraglutide
8%
Biological Marker
8%
Edema
8%
Etidronic Acid
8%
Single Photon Emission Computed Tomography-Computed Tomography
8%
Technetium-99
8%
Adenocarcinoma
8%
Granulomatosis with Polyangiitis
8%
Small Cell Lung Cancer
8%
Distant Metastasis
8%
Head and Neck Squamous Cell Carcinoma
8%
Computer Assisted Tomography
8%
Tertiary Care
8%
Cervical Cancer
8%
Hybrid Imaging
8%
Nuclear Magnetic Resonance
8%
Chronic Hepatitis C
8%
Recurrent Disease
8%
Bone Scintigraphy
8%
Oropharynx Squamous Cell Carcinoma
8%
Bone Metastasis
8%
Diabetes
8%
Brown Adipose Tissue
8%
Thermoregulation
8%
Keyphrases
PET-MRI
100%
Magnetic Resonance Imaging
38%
Positron Emission Tomography
34%
Positron Emission Tomography-computed Tomography (PET-CT)
33%
Early Response
28%
Lung Cancer
23%
FDG Uptake
23%
MR-based Attenuation Correction
20%
18F-fluorodeoxyglucose (18F-FDG)
20%
Computed Tomography
18%
Diffusion Magnetic Resonance Imaging (dMRI)
17%
Liraglutide
17%
Attenuation Correction
17%
FDG Positron Emission Tomography
16%
Total-body PET/CT
11%
Fluorothymidine
11%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
11%
Oncology
11%
Non-small Cell Lung Cancer (NSCLC)
10%
Mini-pig Model
10%
18F-fluorodeoxyglucose PET
10%
Radiotherapy Planning
10%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
10%
Minipig
10%
Glucagon-like
10%
Receptor Agonist
10%
Without Diabetes
10%
A1 Receptor
10%
SUVpeak
10%
PET Quantification
9%
Image Artifacts
9%
Whole-body
9%
Confidence Interval
9%
18F-fluoride PET
8%
Epidermal Growth Factor Receptor
8%
Cold-induced Thermogenesis
8%
Winter Swimming
8%
Oncologists
8%
Treatment Response Evaluation
8%
Tertiary Care
8%
Medical Center
8%
Pancreatic Edema
8%
Pancreatic Volume
8%
Oncologic Imaging
8%
Bone Attenuation
8%
Crizotinib
8%
MR-based Attenuation Map
8%
GLP-1 Receptor Analogues
8%
Clinical Significance
8%
Uncommon Presentation
8%